[A contribution on the antiproteolytic activity quality of phenylbutazone, oxyphenbutazone and sodium salicylate].
D000596:Amino Acids / Q000032:analysis; D000813:Anilides / Q000032:analysis; D003864:Depression, Chemical; D010113:Oxyphenbutazone / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology*; D012710:Serum Albumin, Bovine / Q000032:analysis; D012980:Sodium Salicylate / Q000494:pharmacology*; D014361:Trypsin Inhibitors
D000596:Amino Acids; D000813:Anilides; D014361:Trypsin Inhibitors; D012710:Serum Albumin, Bovine; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D012980:Sodium Salicylate
Ein Beitrag zur antiproteolytischen Wirkungsqualität von Phenylbutazon, Oxyphenbutazon und Natriumsalicylat.